Literature DB >> 19214097

Mortality and morbidity associated with correction of severe cervical hyperextension.

Gregory T Poulter1, Hugh J L Garton, Laurel C Blakemore, Robert N Hensinger, Gregory P Graziano, Frances A Farley.   

Abstract

STUDY
DESIGN: Three case reports of patients with treatment of severe cervical hyperextension.
OBJECTIVE: Cervical hyperextension is a rare spine deformity that is associated with myopathies. Previous reports of surgical correction have reported no major operative complications. This report outlines our experience with 3 patients who experienced significant complications. SUMMARY OF BACKGROUND DATA: The limited literature on the treatment of cervical hyperextension has good to excellent outcomes.
METHODS: Three case reports are presented.
RESULTS: Three cases with severe cervical hyperextension with intraoperative correction had associated morbidity and mortality. One case had a failed intubation requiring tracheotomy. This was followed by a successful posterior release with halo traction for 2 weeks and then an instrumented posterior cervical fusion. This patient died at home 2 weeks after surgery. The second and third cases had an intraoperative spinal cord injury during a posterior release for cervical hyperextension.
CONCLUSION: Patients with severe cervical hyperextension have high neurologic perioperative risk.

Entities:  

Mesh:

Year:  2009        PMID: 19214097     DOI: 10.1097/BRS.0b013e3181947ce4

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  2 in total

1.  Tailor-made management of thoracic scoliosis with cervical hyperextension in muscular dystrophy.

Authors:  A Angelliaume; L Harper; A Lalioui; A Delgove; Y Lefèvre
Journal:  Eur Spine J       Date:  2017-06-07       Impact factor: 3.134

2.  Laminopathies' Treatments Systematic Review: A Contribution Towards a 'Treatabolome'.

Authors:  Antonio Atalaia; Rabah Ben Yaou; Karim Wahbi; Annachiara De Sandre-Giovannoli; Corinne Vigouroux; Gisèle Bonne
Journal:  J Neuromuscul Dis       Date:  2021
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.